Skip to main content
XOMA Royalty Corporation (XOMA)
NASDAQ: XOMA · Real-Time Price · USD
27.45
+1.47 (5.66%)
At close: Mar 9, 2026, 4:00 PM EDT
27.47
+0.02 (0.07%)
After-hours: Mar 9, 2026, 4:24 PM EDT

XOMA Royalty Revenue

XOMA Royalty had revenue of $9.35M in the quarter ending September 30, 2025, with 29.93% growth. This brings the company's revenue in the last twelve months to $47.11M, up 118.02% year-over-year. In the year 2024, XOMA Royalty had annual revenue of $28.49M with 498.72% growth.

Revenue (ttm)
$47.11M
Revenue Growth
+118.02%
P/S Ratio
6.93
Revenue / Employee
$3,623,538
Employees
13
Market Cap
326.34M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202428.49M23.73M498.72%
Dec 31, 20234.76M-1.27M-21.06%
Dec 31, 20226.03M-32.13M-84.21%
Dec 31, 202138.16M8.78M29.86%
Dec 31, 202029.39M11.02M59.96%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Puma Biotechnology 228.37M
C4 Therapeutics 35.95M
X4 Pharmaceuticals 33.98M
Silence Therapeutics 559.00K
Avalo Therapeutics 192.00K
Revenue Rankings

XOMA News

More News